Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

Contributed by: Business Wire

Logo

Business Wire logo

Images

Mytos Co-Founders: Ali Afshar, Ph.D (left), CEO and Ignacio Willats (right). Photo credit: Mytos
Mytos Co-Founders: Ali Afshar, Ph.D (left), CEO and Ignacio Willats (right). Photo credit: Mytos
Mytos Automated Cell Manufacturing System. Photo credit: Mytos
Mytos Automated Cell Manufacturing System. Photo credit: Mytos
Business Wire embedded0

Tags

Pharmaceutical
Research
Oncology
Software
Finance
Medical Devices
Hardware
Genetics
Data Management
Professional Services
Stem Cells
Science
Technology
Mobile/Wireless
Clinical Trials
Biotechnology
Health
Apps/Applications
Series A Funding

More Like This

PR Newswire associated0

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform

Business Wire logo

Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares’ Technology Adoption Partnership Program

ioMotor Neurons (Photo: Business Wire)

bit.bio further expands ioCells™️ range with early access launch of ioMotor Neurons™️ for research and drug discovery in diseases such as amyotrophic lateral sclerosis (ALS)

MiLaboratories co-founders: Dmitry Chudakov, Stan Poslavsky, Dmitry Bolotin, Alexey Nechaev (Photo: Business Wire)

MiLaboratories Secures Series A, Raising Total Funding to $10 Million to Revolutionize the World of Genomic Research

Ori Biotech Unveils IRO Platform at Annual International Society for Cell & Gene Therapy Conference

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™

Business Wire logo

ViroCell Biologics Completes Oversubscribed Financing